Dr Iqbal Malik - chair
Consultant Cardiologist and Honorary Senior Lecturer, Imperial College Healthcare NHS Trust, London
Iqbal Malik is a consultant at Imperial College Healthcare NHS Trust, London. He trained at Peterhouse College, Cambridge and then at Guy's and St Thomas’ Hospital, London. After further training in West London, Dr Malik was appointed as a consultant cardiologist at Imperial College Healthcare NHS Trust, London in 2001. At Hammersmith Hospital, he is director of the catheter laboratories and lead for primary angioplasty. He is lead clinician for revascularisation for North West London Cardiac Network and national clinical lead for web transfer systems. His research interests are in stroke prevention (patent foramen ovale closure and carotid stenting), coronary revascularisation and transcatheter aortic valve implantation.
Rustam Al-Shahi Salman - chair
Professor of clinical neurology, MRC senior clinical fellow, & honorary consultant neurologist, University of Edinburgh / NHS Lothian
Rustam Al-Shahi Salman’s interest in neurology began in medical training in Cambridge and after attending advanced neurology and clinical trials courses in Edinburgh. His clinical and research interests encompass all forms of stroke (subarachnoid and intraparenchymal haemorrhage, in particular), intracranial vascular malformations (whether ruptured or not), and—increasingly—incidentalomas detected on brain imaging (whether in clinical practice, in research studies, or as part of so-called ‘health check-ups’). He also runs a rapid access neurology clinic for his local emergency department.
Poon MTC, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2014;85:660-7.
Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP, for the Scottish Audit of Intracranial Vascular Malformations collaborators. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 2014;311:1661-9
Langhorne P, Fearon P, Rønning OM, Kaste M, Palomaki H, Vemmos K, Kalra L, Indredavik B, Blomstrand C, Rodgers H, Dennis M, Al-Shahi Salman R, Stroke Unit Trialists’ Collaboration. Stroke unit care benefits patients with intracerebral haemorrhage: systematic review and meta-analysis. Stroke 2013;44(11):3044-9
Declaration of interests: None
Professor Anthony Rudd
National Clinical Director for Stroke, NHS England
Tony Rudd is Professor of Stroke Medicine at Kings College London and a consultant stroke physician at Guy’s and St Thomas’ NHS Foundation Trust. For the last 3 years he has been the London Clinical Director for stroke and since April 2013 the National Clinical Director for Stroke. He is Vice Chairman of the Stroke Association and is the Stroke Programme Director at the Royal College of Physicians, London responsible for the development of the National Clinical Guidelines for stroke and the National Stroke audits. He was awarded a CBE in the Queen’s birthday honours in 2013.
Bray BD, Ayis S, Campbell J, Cloud GC, James M, Hoffman A, Tyrrell PJ, Wolfe CD, Rudd AG. Associations between Stroke Mortality and Weekend Working by Stroke Specialist Physicians and Registered Nurses: Prospective Multicentre Cohort Study. PLoS Med. 2014 Aug 19;11(8):e1001705. doi: 10.1371/journal.pmed.1001705
Morris S, Hunter RM, Ramsay AI, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Schwamm LH, Turner SJ, Tyrrell PJ, Wolfe CD, Fulop NJ. Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis. BMJ. 2014 Aug 5;349:g4757. doi: 10.1136/bmj.g4757
Bray BD, Ayis S, Campbell J, Hoffman A, Roughton M, Tyrrell PJ, Wolfe CD, Rudd AG. Associations between the organisation of stroke services, process of care, and mortality in England: prospective cohort study. BMJ. 2013 May 10;346:f2827. doi: 10.1136/bmj.f2827
Professor Phil White
Professor of Interventional and Diagnostic Neurology, Newcastle University
Phil White holds the chair of Neuroradiology at Newcastle University. He is the Co-Principal Investigator of three ongoing randomised trials in stroke amongst a wide portfolio of ongoing research. In 2009 he was appointed chair of Acute Studies Group of the UK Stroke Research Network. He represents Royal College of Radiologists on the Intercolleagiate Stroke Working Party and chairs British Neuroradiologists Standards Committee. He is secretary of the UK Neurointerventional Group, chairs the European Society of Minimally Invasive Neurological Therapy Research Committee and is on the editorial board of the Journal of Neurointerventional Surgery. He is also a specialist advisor to a number of bodies including NICE, Wellcome and HTA.
Decalaration of interests:
Consultancy work with Microvention, Codman, Covidien for educational purposes
Institutional research funding: Ibex Innovations, Microvention
Travel support in the last three years from Microvention, Codman
Academic interests: National Stroke Strategy, Intercollegiate Stroke working party, Stroke Association, Stroke research Network
Dr William Whiteley
MRC Clinician Scientist & Honorary Consultant Neurologist, University of Edinburgh & NHS Lothian
Will Whiteley is an MRC Clinician Scientist at the University of Edinburgh. His research interests are the targeting of acute treatments for stroke, the development of better methods to predict outcome after stroke, and the use of routinely collected data. As a CSO Clinical Academic Training Fellow, he studied the use of blood biomarkers in stroke, and read for an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine. He is a clinical neurologist for NHS Lothian, actively involved in stroke/TIA clinics, stroke thrombolysis and general neurology.
Jonathan Emberson PhD, Prof Kennedy R Lees MD, Prof Patrick Lyden MD, Lisa Blackwell BSc, Prof Gregory Albers MD, Prof Erich Bluhmki PhD,et al,for the Stroke Thrombolysis Trialists' Collaborative Group Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.The Lancet - 6 August 2014 . DOI: 10.1016/S0140-6736(14)60584-5
William N. Whiteley, PhD; Douglas Thompson, BSc; Gordon Murray, PhD; Geoff Cohen, MA; Richard I. Lindley, FRCP; Joanna Wardlaw, FRCR, FRCP; Peter Sandercock, FRCPE; on behalf of the IST-3 Collaborative Group. Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome.An Analysis of the Third International Stroke Trial. Stroke.2014; 45: 1000-1006.Published online before print March 6, 2014
William N Whiteley, Harold P Adams, Jr, Philip MW Bath,c Eivind Berge, Per Morten Sandset, Martin Dennis, Gordon D Murray, Ka-Sing Lawrence Wong, and Peter AG Sandercock.Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol. Jun 2013; 12(6): 539–545.doi: 10.1016/S1474-4422(13)70079-6
Declaration of interests: None
Professor Peter Langhorne
Professor of Stroke care, University of Glasgow
Peter Langhorne is Professor of Stroke Care at the University of Glasgow, UK. His research work has focussed on the effectiveness of different treatment strategies for stroke patients, including service delivery and stroke rehabilitation. During the last 20 years he has been a coordinator and grant holder for randomised clinical trials of occupational therapy, nursing, physiotherapy and early mobilisation. He also has coordinated systematic reviews and meta-analyses of trials of stroke units, early supported discharge services, outpatient therapy services, intensive physiotherapy input, and stroke liaison worker services. He is the coordinating editor of the Cochrane Stroke Group and has worked within the Cochrane collaboration more broadly to encourage the development of evidence-based practice.
Declaration of interests: None
Dr Arindam Kar
Consultant in Stroke Medicine, HASU Clinical Lead, Imperial College Healthcare NHS trust
Arindam Kar is a consultant stroke physician at Imperial College Healthcare NHS Trust, London. He graduated from Cambridge and Oxford Universities before completing his geriatric and stroke training in north London. He was appointed consultant stroke physician at Imperial in 2009 and is currently the hyper-acute stroke unit clinical lead at Charing Cross Hospital. His interests include improving the delivery of hyper-acute stroke care, atrial fibrillation and stroke subspecialty training.
Further speaker biographies and declarations will be uploaded in due course.